Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "Combination Treatment With Sonrotoclax (BGB-11417), a 2nd-Gen BCL2i, and Zanubrutinib in Pts With TN-CLL/SLL"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mary Ann Anderson
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mary Ann Anderson
172 views
December 14, 2023
Login to view comments.
Click here to Login
Leukemia